METABOLIC SYNDROME: PATHOPHYSIOLOGY, CARDIOVASCULAR RISK, AND MODERN THERAPEUTIC APPROACHES

Authors

  • Gulzoda Rabimqulovna Shodiyeva,Murtozoyeva O'g'iloy Saydulla qizi,Aslonov Shahzod Ulug'bek o'g'li,Absalamov Shoxjahon Axror o'g'li PhD Assistant, Department of Internal Medicine Samarqand State Medical University,6th-year student of the Faculty of Pediatrics,3th-year student of the Faculty of Pediatrics,1th-year student of the Faculty of Pharmacy

Keywords:

Metabolic syndrome, insulin resistance, central obesity, dyslipidemia, hypertension, cardiovascular risk, inflammation, endothelial dysfunction.

Abstract

Metabolic syndrome (MetS) represents a cluster of interrelated metabolic abnormalities that significantly increase the risk of cardiovascular disease and type 2 diabetes mellitus. It is characterized by central obesity, insulin resistance, hypertension, dyslipidemia, and impaired glucose metabolism. The syndrome has become a global public health concern due to the rising prevalence of obesity and sedentary lifestyles. The underlying pathophysiology involves complex interactions between adipose tissue dysfunction, chronic low-grade inflammation, insulin resistance, endothelial dysfunction, and neurohormonal activation. Individuals with metabolic syndrome have a two- to threefold increased risk of cardiovascular events and a fivefold higher risk of developing type 2 diabetes. Modern therapeutic strategies focus on lifestyle modification, pharmacological management of individual components, and emerging therapies targeting insulin resistance and inflammatory pathways. This article reviews the pathophysiological mechanisms, cardiovascular implications, diagnostic criteria, and current evidence-based treatment approaches for metabolic syndrome.

References

1. Karimov Sh.I., Axmedov R.A. Internal Medicine: Metabolic Disorders.

Karimov ShI, Axmedov RA. Internal Medicine: Metabolic and Endocrine Disorders. Tashkent: Abu Ali ibn Sino Medical Publishing House; 2019. 348 p.

2. Saidov M.S., Rakhimov B.T. Cardiometabolic Risk Factors in Clinical Practice.

Saidov MS, Rakhimov BT. Internal Diseases: Cardiovascular and Metabolic Disorders. Tashkent: Yangi Asr Avlodi Publishing; 2021. 412 p.

3. Yuldashev A.A., Tursunov F.F. Metabolic Syndrome and Its Cardiovascular Complications.

Yuldashev AA, Tursunov FF. Metabolic syndrome and cardiovascular complications: modern diagnostic and therapeutic approaches. Medical and Time (Tibbiyot va Zamon). 2022;4(52):34–41.

4. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome.

International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: IDF; 2006.

Downloads

Published

2026-02-17

Conference Proceedings Volume

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.